INFORMAZIONI SU QUESTO EPISODIO
What would it take to prove that longevity medicine works?
Professor Brian Kennedy, Distinguished Professor of Biochemistry and Physiology at the National University of Singapore and former president and CEO of the Buck Institute, joins Pierre Jacob and Meronn Jacob on Transcribed. We recorded this conversation in person at the Longevity Summit in Dublin.
As a PhD student in Leonard Guarente's lab at MIT, Brian co-authored the 1995 yeast paper that first tied the SIR genes to aging and helped launch the sirtuin field. Three decades later he runs human studies in Singapore, where the government is putting S$350 million into healthy longevity research.
His message is unusually sober for this field. Translation is speeding up, he says, while funding for basic discovery science has dried up, and we still don't understand what aging is at the molecular level. He explains why doctors resist the idea of treating aging, why there is no perfect design for a longevity trial, and why testing drugs on the fittest people makes a signal very hard to find.
We also ask him which biomarkers he trusts, what he makes of tech CEOs promising to cure all disease in 10 years, where he draws the line with longevity clinics, and what he would do with $100 billion. His answer: run from shiny objects and go for the low-hanging fruit first.
In this conversation:
◼️ How a yeast lab at MIT started studying aging
◼️ Why he moved from the Buck Institute to Singapore
◼️ How the longevity field went from fringe to front page
◼️ Three decades of working with Matt Kaeberlein
◼️ Why medicine resists treating aging
◼️ How to design a human longevity trial
◼️ AI in his lab: what works, what is hype
◼️ Which aging clocks he trusts
◼️ "Cure all disease in 10 years"?
◼️ Longevity clinics: safety and transparency
◼️ Where he would put $100 billion
◼️ His advice for people entering the field
Transcribed Podcast: in-person interviews with scientists, founders, and industry experts shaping the future of biotech and pharma.
New episodes every Tuesday at 16:00 (Europe/Berlin).
🎙️ Watch all episodes: https://www.youtube.com/@TranscribedPod
📥 Free Biotech Starter Pack: https://transcribedpod.com
📸 Instagram: @transcribedpod
📧 thetranscribedpod@gmail.com
🎵 Jingle composed by Tembeh: https://open.spotify.com/artist/4s9JmadJjVdYQ6YxYtJgja
⚠️ Disclaimer: For information and education only. Not medical, financial, investment, tax or legal advice. Guests share their own experiences and opinions, not necessarily those of Transcribed or its hosts. Nothing here is a recommendation to start, stop or change any treatment, supplement or investment; consult a qualified professional about your own situation. Mentions of companies, clinics or products are not endorsements, and Transcribed accepts no liability for decisions based on this content.
00:00 Introducing Brian Kennedy
00:29 Studying aging in yeast at MIT
01:19 Has discovery slowed down?
02:31 From the Buck Institute to Singapore
03:58 From fringe to front page
05:01 Working with Matt Kaeberlein
06:13 Why medicine resists longevity
08:03 What stands between us and solved aging
10:17 Designing a human longevity trial
11:38 The healthy volunteer problem
13:25 AI in the lab: useful or overhyped?
15:17 Which aging clocks to trust
16:40 Cure all disease in 10 years?
18:49 Longevity clinics: safety and transparency
21:05 Where he would put $100 billion
23:44 Advice for newcomers